ReviewCancer discovery2019

Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors.

Ariella B Hanker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.